Document
IPR2019-00345, No. 1022-22 Exhibit - Huttner, W B, Determination and Occurrence of Tyrosine O Sulfate in Proteins, 107 Methods in Enzymology 200 1984 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1022-22 Exhibit - Huttner, W B, Determination and Occurrence of Tyrosine O Sulfate in Proteins, 107 Methods in Enzymology 200 1984 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1028-28 Exhibit - Wang, YJ, Parenteral Products of Peptides and Proteins, in Pharmaceutical Dosage Forms Parenteral Medications Volume 1 1992 (P.T.A.B. Nov. 19, 2018...
Cite Document
IPR2019-00345, No. 1028-28 Exhibit - Wang, YJ, Parenteral Products of Peptides and Proteins, in Pharmaceutical Dosage Forms Parenteral Medications Volume 1 1992 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1003-3 Exhibit - Declaration of Christian Schoneich, PhD (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1003-3 Exhibit - Declaration of Christian Schoneich, PhD (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1042 Exhibit - Liddle, et al, Cholecystokinin Bioactivity in Human Plasma, 75 J Clin Invest 1144 1985 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1042 Exhibit - Liddle, et al, Cholecystokinin Bioactivity in Human Plasma, 75 J Clin Invest 1144 1985 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1018 Exhibit - US Patent Publication No 20030104996 to Li et al (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1018 Exhibit - US Patent Publication No 20030104996 to Li et al (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1045 Exhibit - Graf, et al, ¿¿¿Iron catalyzed Hydroxyl Radical Formation,¿¿¿ 259 J Bio Chem 3620 1984 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1045 Exhibit - Graf, et al, ¿¿¿Iron catalyzed Hydroxyl Radical Formation,¿¿¿ 259 J Bio Chem 3620 1984 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1031 Exhibit - Uffelman, W, Unexpected Shortfalls of Two Nuclear Medicine Pharmaceuticals, 42 J Nuc Med 16N 2001 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1031 Exhibit - Uffelman, W, Unexpected Shortfalls of Two Nuclear Medicine Pharmaceuticals, 42 J Nuc Med 16N 2001 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1044 Exhibit - Banga, AK, Structure and Analysis of Therapeutic Peptides and Proteins 2006 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1044 Exhibit - Banga, AK, Structure and Analysis of Therapeutic Peptides and Proteins 2006 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1032 Exhibit - US Patent No 5,272,135 to Takruri (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1032 Exhibit - US Patent No 5,272,135 to Takruri (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1021 Exhibit - Yagami, et al, Stabilization of a tyrosine O sulfate residue by a cationic functional group , 56 J Peptide Res 239 2000 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1021 Exhibit - Yagami, et al, Stabilization of a tyrosine O sulfate residue by a cationic functional group , 56 J Peptide Res 239 2000 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1017 Exhibit - Nema et al, Excipients and Their Use in Injectable Products, 51 PDA J of Pharma Sci and Tech 166 1997 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1017 Exhibit - Nema et al, Excipients and Their Use in Injectable Products, 51 PDA J of Pharma Sci and Tech 166 1997 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1037 Exhibit - Jensen et al, Metal Catalyzed Oxidation of Brain Derived Neurotrophic Factor BDNF Selectivity and Conformational Consequences of Histidine Modification, 20...
Cite Document
IPR2019-00345, No. 1037 Exhibit - Jensen et al, Metal Catalyzed Oxidation of Brain Derived Neurotrophic Factor BDNF Selectivity and Conformational Consequences of Histidine Modification, 2000 (P.T.A.B
+ More Snippets
Document
IPR2019-00345, No. 1011 Exhibit - Rational Design of Stable Protein Formulations Theory and Practice, Chapters 5 8 Carpenter and Manning, ed, April 30, 2002 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1011 Exhibit - Rational Design of Stable Protein Formulations Theory and Practice, Chapters 5 8 Carpenter and Manning, ed, April 30, 2002 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1025 Exhibit - Marseigne, et al, Full Agonists of CCK8 Containing a Nonhydrolyzable Sulfated Tyrosine Residue, 32 J Med Chem 445 1989 (P.T.A.B. Nov. 19, 2018)
Cite Document
IPR2019-00345, No. 1025 Exhibit - Marseigne, et al, Full Agonists of CCK8 Containing a Nonhydrolyzable Sulfated Tyrosine Residue, 32 J Med Chem 445 1989 (P.T.A.B. Nov. 19, 2018)
+ More Snippets
Document
IPR2019-00345, No. 1013 Exhibit - Akers et al, Peptides and Proteins as Parenteral Solutions, in Pharmaceutical Formulation Development of Peptides and Proteins 2000 (P.T.A.B. Nov. 19, 201...
Cite Document
IPR2019-00345, No. 1013 Exhibit - Akers et al, Peptides and Proteins as Parenteral Solutions, in Pharmaceutical Formulation Development of Peptides and Proteins 2000 (P.T.A.B. Nov. 19, 2018)
+ More Snippets